A03_17-R-0033.docx

W81XWH-17-R-0033

SECTION SF 30 BLOCK 14 CONTINUATION PAGE

SUMMARY OF CHANGES

SECTION B - SUPPLIES OR SERVICES AND PRICES

CLIN 0011

This CLIN has been renumbered to CLIN 0021.

The CLIN description has changed from Optional Lab Short Suspense Requirement to Deleted.

The CLIN extended description has changed from:

All Operations and Maintenance (O&M) labor required to perform optional Lab short suspense requirement tasks as outlined in the PWS paragraph 4.17.

To:

Deleted.

The unit of issue Job has been deleted.

The option status has changed from Option to No Status.

CLIN 0012

This CLIN has been renumbered to CLIN 0022.

The CLIN description has changed from Optional Lab Short Suspense Requirement to Deleted.

The CLIN extended description has changed from:

All Research Development Test & Evaluation (RDT&E) labor required to perform optional Lab short suspense requirement tasks as outlined in the PWS paragraph 4.17.

To:

Deleted.

CLIN 0014

This CLIN has been renumbered to CLIN 0011.

CLIN 0015

This CLIN has been renumbered to CLIN 0012.

CLIN 0016

This CLIN has been renumbered to CLIN 0014.

CLIN 0017

This CLIN has been renumbered to CLIN 0015.

CLIN 0018

This CLIN has been renumbered to CLIN 0016.

CLIN 0019

This CLIN has been renumbered to CLIN 0017.

CLIN 0020

The CLIN description has changed from Surge DETA Services Advanced Development to Deleted.

The CLIN extended description has changed from:

All labor required to perform surge services in support of DETA as outlined in the PWS paragraph 4.13 - 4.15.

To:

Deleted.

CLIN 1011

This CLIN has been renumbered to CLIN 1020.

The CLIN description has changed from Optional Lab Short Suspense Requirement to Deleted.

The CLIN extended description has changed from:

All Operations and Maintenance (O&M) labor required to perform optional Lab short suspense requirement tasks as outlined in the PWS paragraph 4.17.

To:

Deleted.

CLIN 1012

This CLIN has been renumbered to CLIN 1021.

The CLIN description has changed from Optional Lab Short Suspense Requirement to Deleted.

The CLIN extended description has changed from:

All Research Development Test & Evaluation (RDT&E) labor required to perform optional Lab short suspense requirement tasks as outlined in the PWS paragraph 4.17.

To:

Deleted.

CLIN 1014

This CLIN has been renumbered to CLIN 1011.

CLIN 1015

This CLIN has been renumbered to CLIN 1012.

CLIN 1016

This CLIN has been renumbered to CLIN 1014.

CLIN 1017

This CLIN has been renumbered to CLIN 1015.

CLIN 1018

This CLIN has been renumbered to CLIN 1016.

CLIN 1019

The CLIN extended description has changed from:

All labor required to perform surge services in support of DETA as outlined in the PWS paragraph 4.13 - 4.15.

To:

Deleted.

CLIN 2011

This CLIN has been renumbered to CLIN 2020.

The CLIN description has changed from Optional Lab Short Suspense Requirement to Deleted.

The CLIN extended description has changed from:

All Operations and Maintenance (O&M) labor required to perform optional Lab short suspense requirement tasks as outlined in the PWS paragraph 4.17.

To:

Deleted.

CLIN 2012

This CLIN has been renumbered to CLIN 2021.

The CLIN description has changed from Optional Lab Short Suspense Requirement to Deleted.

The CLIN extended description has changed from:

All Research Development Test & Evaluation (RDT&E) labor required to perform optional Lab short suspense requirement tasks as outlined in the PWS paragraph 4.17.

To:

Deleted.

CLIN 2014

This CLIN has been renumbered to CLIN 2011.

CLIN 2015

This CLIN has been renumbered to CLIN 2012.

CLIN 2016

This CLIN has been renumbered to CLIN 2014.

CLIN 2017

This CLIN has been renumbered to CLIN 2015.

CLIN 2018

This CLIN has been renumbered to CLIN 2016.

CLIN 2019

The CLIN extended description has changed from:

All labor required to perform surge services in support of DETA as outlined in the PWS paragraph 4.13 - 4.15.

To:

Deleted.

CLIN 3011

This CLIN has been renumbered to CLIN 3020.

The CLIN description has changed from Optional Lab Short Suspense Requirement to Deleted.

The CLIN extended description has changed from:

All Operations and Maintenance (O&M) labor required to perform optional Lab short suspense requirement tasks as outlined in the PWS paragraph 4.17.

To:

Deleted.

CLIN 3012

This CLIN has been renumbered to CLIN 3021.

The CLIN description has changed from Optional Lab Short Suspense Requirement to Deleted.

The CLIN extended description has changed from:

All Research Development Test & Evaluation (RDT&E) labor required to perform optional Lab short suspense requirement tasks as outlined in the PWS paragraph 4.17.

To:

Deleted.

CLIN 3014

This CLIN has been renumbered to CLIN 3011.

CLIN 3015

This CLIN has been renumbered to CLIN 3012.

CLIN 3016

This CLIN has been renumbered to CLIN 3014.

CLIN 3017

This CLIN has been renumbered to CLIN 3015.

CLIN 3018

This CLIN has been renumbered to CLIN 3016.

CLIN 3019

The CLIN extended description has changed from:

All labor required to perform surge services in support of DETA as outlined in the PWS paragraph 4.13 - 4.15.

To:

Deleted.

CLIN 4011

This CLIN has been renumbered to CLIN 4021.

The CLIN description has changed from Optional Lab Short Suspense Requirement to Deleted.

The CLIN extended description has changed from:

All labor Operations and Maintenance (O&M) required to perform optional Lab short suspense requirement tasks as outlined in the PWS paragraph 4.17.

To:

Deleted.

CLIN 4012

This CLIN has been renumbered to CLIN 4022.

The CLIN description has changed from Optional Lab Short Suspense Requirement to Deleted.

The CLIN extended description has changed from:

All Research Development Test & Evaluation (RDT&E) labor required to perform optional Lab short suspense requirement tasks as outlined in the PWS paragraph 4.17.

To:

Deleted.

CLIN 4014

This CLIN has been renumbered to CLIN 4011.

CLIN 4015

This CLIN has been renumbered to CLIN 4012.

CLIN 4016

This CLIN has been renumbered to CLIN 4014.

CLIN 4017

This CLIN has been renumbered to CLIN 4015.

CLIN 4018

This CLIN has been renumbered to CLIN 4016.

CLIN 4019

This CLIN has been renumbered to CLIN 4017.

CLIN 4020

The CLIN extended description has changed from:

All labor required to perform surge services in support of DETA as outlined in the PWS paragraph 4.13 - 4.15.

To:

Deleted.

SECTION E - INSPECTION AND ACCEPTANCE

The following have been added by reference:

SECTION F - DELIVERIES OR PERFORMANCE

The following Delivery Schedule Item has been deleted from CLIN 0011:

POP 30-MAR-2018 TO

29-MAR-2019

WRAIR

ATTN: HIV DIAGNOSTIC AND REFERENCE LAB 9100

ROAD, BLDG 508

SILVER SPRING, MD MD 20910

301-319-3173 FOB: Destination

W74MYF

The following Delivery Schedule Item has been deleted from CLIN 0020:

POP 30-MAR-2018 TO

29-MAR-2019

WRAIR

ATTN: HIV DIAGNOSTIC AND REFERENCE LAB 9100

ROAD, BLDG 508

SILVER SPRING, MD MD 20910

301-319-3173

W74MYF

The following Delivery Schedule Item has been deleted from CLIN 1019:

POP 30-MAR-2019 TO

29-MAR-2020

WRAIR

ATTN: HIV DIAGNOSTIC AND REFERENCE LAB 9100

ROAD, BLDG 508

SILVER SPRING, MD MD 20910

301-319-3173

W74MYF

The following Delivery Schedule Item has been deleted from CLIN 2019:

POP 30-MAR-2020 TO

29-MAR-2021

WRAIR

ATTN: HIV DIAGNOSTIC AND REFERENCE LAB 9100

ROAD, BLDG 508

SILVER SPRING, MD MD 20910

301-319-3173

W74MYF

The following Delivery Schedule Item has been deleted from CLIN 3019:

POP 30-MAR-2021 TO

29-MAR-2022

WRAIR

ATTN: HIV DIAGNOSTIC AND REFERENCE LAB 9100

ROAD, BLDG 508

SILVER SPRING, MD MD 20910

301-319-3173

W74MYF

The following Delivery Schedule Item has been deleted from CLIN 4020:

POP 30-MAR-2022 TO

29-MAR-2023

WRAIR

ATTN: HIV DIAGNOSTIC AND REFERENCE LAB 9100

ROAD, BLDG 508

SILVER SPRING, MD MD 20910

301-319-3173

W74MYF

SECTION I - CONTRACT CLAUSES

The following have been deleted:

SECTION K - REPRESENTATIONS, CERTIFICATIONS AND OTHER STATEMENTS OF OFFERORS

The following have been modified:

52.204-8 ANNUAL REPRESENTATIONS AND CERTIFICATIONS (JAN 2017)

(a)(1) The North American Industry Classification System (NAICS) code for this acquisition is 541714.

(2) The small business size standard is 1,000 employees.

(3) The small business size standard for a concern which submits an offer in its own name, other than on a construction or service contract, but which proposes to furnish a product which it did not itself manufacture, is 500 employees.

(b)(1) If the provision at 52.204-7, System for Award Management, is included in this solicitation, paragraph (d) of this provision applies.

(2) If the provision at 52.204-7 is not included in this solicitation, and the offeror is currently registered in System for Award Management (SAM), and has completed the Representations and Certifications section of SAM electronically, the offeror may choose to use paragraph (d) of this provision instead of completing the corresponding individual representations and certifications in the solicitation. The offeror shall indicate which option applies by checking one of the following boxes:

( ) Paragraph (d) applies.

( ) Paragraph (d) does not apply and the offeror has completed the individual representations and certifications in the solicitation.

(c) (1) The following representations or certifications in SAM are applicable to this solicitation as indicated:

(i) 52.203-2, Certificate of Independent Price Determination. This provision applies to solicitations when a firm-fixed-price contract or fixed-price contract with economic price adjustment is contemplated, unless—

(A) The acquisition is to be made under the simplified acquisition procedures in Part 13;

(B) The solicitation is a request for technical proposals under two-step sealed bidding procedures; or

(C) The solicitation is for utility services for which rates are set by law or regulation.

(ii) 52.203-11, Certification and Disclosure Regarding Payments to Influence Certain Federal Transactions. This provision applies to solicitations expected to exceed $150,000.

(iii) 52.203-18, Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements or Statements--Representation. This provision applies to all solicitations.

(iv) 52.204-3, Taxpayer Identification. This provision applies to solicitations that do not include the provision at 52.204-7, System for Award Management.

(v) 52.204-5, Women-Owned Business (Other Than Small Business). This provision applies to solicitations that—

(A) Are not set aside for small business concerns;

(B) Exceed the simplified acquisition threshold; and

(C) Are for contracts that will be performed in the United States or its outlying areas.

(vi) 52.209-2; Prohibition on Contracting with Inverted Domestic Corporations--Representation.

(vii) 52.209-5; Certification Regarding Responsibility Matters. This provision applies to solicitations where the contract value is expected to exceed the simplified acquisition threshold.

(viii) 52.209-11, Representation by Corporations Regarding elinquent Tax Liability or a Felony Conviction under any Federal Law. This provision applies to all solicitations.

(ix) 52.214-14, Place of Performance--Sealed Bidding. This provision applies to invitations for bids except those in which the place of performance is specified by the Government.

(x) 52.215-6, Place of Performance. This provision applies to solicitations unless the place of performance is specified by the Government.

(xi) 52.219-1, Small Business Program Representations (Basic & Alternate I). This provision applies to solicitations when the contract will be performed in the United States or its outlying areas.

(A) The basic provision applies when the solicitations are issued by other than DoD, NASA, and the Coast Guard.

(B) The provision with its Alternate I applies to solicitations issued by DoD, NASA, or the Coast Guard.

(xii) 52.219-2, Equal Low Bids. This provision applies to solicitations when contracting by sealed bidding and the contract will be performed in the United States or its outlying areas.

(xiii) 52.222-22, Previous Contracts and Compliance Reports. This provision applies to solicitations that include the clause at 52.222-26, Equal Opportunity.

(xiv) 52.222-25, Affirmative Action Compliance. This provision applies to solicitations, other than those for construction, when the solicitation includes the clause at 52.222-26, Equal Opportunity.

(xv) 52.222-38, Compliance with Veterans' Employment Reporting Requirements. This provision applies to solicitations when it is anticipated the contract award will exceed the simplified acquisition threshold and the contract is not for acquisition of commercial items.

(xvi) 52.222-57, Representation Regarding Compliance with Labor Laws (Executive Order 13673). This provision applies to solicitations expected to exceed $50 million which are issued from October 25, 2016 through April 24, 2017, and solicitations expected to exceed $500,000, which are issued after April 24, 2017.

Note to paragraph (c)(1)(xvi): By a court order issued on October 24, 2016, 52.222-57 is enjoined indefinitely as of the date of the order. The enjoined paragraph will become effective immediately if the court terminates the injunction. At that time, DoD, GSA, and NASA will publish a document in the Federal Register advising the public of the termination of the injunction.

(xvii) 52.223-1, Biobased Product Certification. This provision applies to solicitations that require the delivery or specify the use of USDA-designated items; or include the clause at 52.223-2, Affirmative Procurement of Biobased Products Under Service and Construction Contracts.

(xviii) 52.223-4, Recovered Material Certification. This provision applies to solicitations that are for, or specify the use of, EPA- designated items.

(xix) 52.223-22, Public Disclosure of Greenhouse Gas Emissions and Reduction Goals--Representation. This provision applies to solicitations that include the clause at 52.204-7.)

(xx) 52.225-2, Buy American Certificate. This provision applies to solicitations containing the clause at 52.225-1.

(xxi) 52.225-4, Buy American--Free Trade Agreements--Israeli Trade Act Certificate. (Basic, Alternates I, II, and III.) This provision applies to solicitations containing the clause at 52.225- 3.

(A) If the acquisition value is less than $25,000, the basic provision applies.

(B) If the acquisition value is $25,000 or more but is less than $50,000, the provision with its Alternate I applies.

(C) If the acquisition value is $50,000 or more but is less than $77,533, the provision with its Alternate II applies.

(D) If the acquisition value is $77,533 or more but is less than $100,000, the provision with its Alternate III applies.

(xxii) 52.225-6, Trade Agreements Certificate. This provision applies to solicitations containing the clause at 52.225-5.

(xxiii) 52.225-20, Prohibition on Conducting Restricted Business Operations in Sudan--Certification. This provision applies to all solicitations.

(xxiv) 52.225-25, Prohibition on Contracting with Entities Engaging in Certain Activities or Transactions Relating to Iran—Representation and Certification. This provision applies to all solicitations.

(xxv) 52.226-2, Historically Black College or University and Minority Institution Representation. This provision applies to solicitations for research, studies, supplies, or services of the type normally acquired from higher educational institutions.

(2) The following representations or certifications are applicable as indicated by the Contracting Officer:

[Contracting Officer check as appropriate.]

(i) 52.204-17, Ownership or Control of Offeror.

(ii) 52.204-20, Predecessor of Offeror.

(iii) 52.222-18, Certification Regarding Knowledge of Child Labor for Listed End Products.

(iv) 52.222-48, Exemption from Application of the Service Contract Labor Standards to Contracts for Maintenance, Calibration, or Repair of Certain Equipment--Certification.

(v) 52.222-52 Exemption from Application of the Service Contract Labor Standards to Contracts for Certain Services--Certification.

(vi) 52.223-9, with its Alternate I, Estimate of Percentage of Recovered Material Content for EPA-Designated Products (Alternate I only).

(vii) 52.227-6, Royalty Information.

(A) Basic.

(B) Alternate I.

(viii) 52.227-15, Representation of Limited Rights Data and Restricted Computer Software.

(d) The offeror has completed the annual representations and certifications electronically via the SAM website accessed through https://www.acquisition.gov. After reviewing the SAM database information, the offeror verifies by submission of the offer that the representations and certifications currently posted electronically that apply to this solicitation as indicated in paragraph (c) of this provision have been entered or updated within the last 12 months, are current, accurate, complete, and applicable to this solicitation (including the business size standard applicable to the NAICS code referenced for this solicitation), as of the date of this offer and are incorporated in this offer by reference (see FAR 4.1201); except for the changes identified below [offeror to insert changes, identifying change by clause number, title, date]. These amended representation(s) and/or certification(s) are also incorporated in this offer and are current, accurate, and complete as of the date of this offer.

FAR Clause Title Date Change

Any changes provided by the offeror are applicable to this solicitation only, and do not result in an update to the representations and certifications posted on SAM.

(End of provision)

SECTION L - INSTRUCTIONS, CONDITIONS AND NOTICES TO BIDDERS

INSTRUCTIONS TO OFFERORS

PROPOSAL SUBMISSION (Section L)

North American Industry Classification System (NAICS): The NAICS code and small business size standard for this acquisition is 541714 with a size standard of 1,000 employees.

POC: The Contract Specialist (CS) is the POC for this acquisition. Any questions or concerns regarding this acquisition shall be submitted electronically via e-mail to John Fitzsimmons at john.l.fitzsimmons8.civ@mail.mil.

Site Visit: A Request for Information (RFI) was posted 10 November 2016 which included information regarding a by invitation Industry Day which was held on 26 January 2017. No additional site visits are anticipated.

Question Submission Requirements: Offeror's who have questions pertaining to the solicitation requirements shall submit questions no later than 10:00AM Eastern Standard Time (EST) on 21 December 2017 to the Contract Specialist at john.l.fitzsimmons8.civ@mail.mil. All questions should be submitted electronically. Answers to all relevant and appropriate questions will be issued via amendment to the solicitation

Follow up questions are due by 8 January 2018 2PM EST.

Proposal Due Date: No Later Than: 18 January 2018 2PM EST submitted to john.l.fitzsimmons8.civ@mail.mil

Submission of Offers: The Offeror’s proposal shall be electronically submitted as set forth below. Failure to submit all documents concurrently and in accordance with these instructions may render a proposal unacceptable. The use of hyperlinks in proposals is prohibited. Proprietary information shall be clearly marked.

Proposal Content and Format Instructions: The Offeror’s submission shall be submitted electronically to CS John Fitzsimmons via email john.l.fitzsimmons8.civ@mail.mil and include three separate volumes: Volume I – Business Proposal inclusive of Cost Proposal, Volume II – Non-Cost / Price Technical Proposal, and Volume III - Past Performance, small business participation plan . Proposal content shall be no smaller than Times New Roman font 12 pitch. Exhibits, graphics, charts, captions, etc., shall be no smaller than Times New Roman font10 pitch.

Format: The submission shall be clearly indexed and logically assembled. Each volume shall be clearly identified and shall begin at the top of a page. All pages of each volume shall be appropriately numbered and identified by the complete company name, date and Request for Proposal (RFP) number in the header and/or footer. A Table of Contents shall be provided. MS Word (doc) files shall use the following page setup parameters:

Margins - Top, Bottom Left, Right – 1 "Gutter - 0" From Edge - Header, footer - 0.5" Page Size, Width - 8.5" Page Size, Height - 11"

NOTE: 11x17 Folded pages are acceptable for tables/graphic representations; however, each 11x17 page counts as two (2) pages.

Electronic File Packaging: The Non-Cost/Price proposal shall be submitted in MS Word or searchable PDF format. The Cost/Price proposal shall be submitted in MS Word or MS Excel 2000 or higher, but not greater than MS Word or MS Excel 2007 format. The firewall utilized by the Government contracting office does not authorize or accept zip files.

Incumbent Personnel: In accordance with Federal Acquisition Regulation (FAR) 52.222-17 (No displacement of Qualified Workers), incumbent personnel must be afforded the opportunity to obtain employment with a successor contractor. See 29 CFR section 541 for the definition of professional employees. Offeror's must submit an e-mail providing the Company Name, Company POC for Personnel with Contact Information to the CS at john.l.fitzsimmons8.civ@mail.mil Time. The CS will consolidate the contact information and shall provide a list of the vendors expressing interest in the requirement to the incumbent personnel. If the incumbents are interested in pursuing employment with your company, they will contact you.

Content Requirement: All information shall be confined to the appropriate file. The Offeror shall confine submissions to essential matters, sufficient to define the proposal in a concise manner to permit a complete and accurate evaluation of each proposal. Content shall be indexed (cross-indexed, as appropriate) and logically assembled. Each file of the proposal shall consist of a Table of Contents, Summary Section, and the Narrative discussion. The Summary Section shall contain a brief abstract of the file. Proprietary information shall be clearly marked. The following shall be included in the Narrative discussion:

VOLUME I - Business Proposal Inclusive of Cost Proposal: The volume shall contain the following section documentations:

1. Company Cover Letter

1. SF 33 - Solicitation, Offer and Award with Blocks 12 - 17 completed by the Offeror signed by an authorized official of the firm.

1. Acknowledgment of Solicitation Amendments

1. Contract Administration Data

1. Representations and Certifications at FAR 52.204-8 (FAR 52.204-8(b) for those representations and certifications that the Offeror shall complete electronically) and Other Statements of Offeror's. Offers that fail to furnish required representations or information, or reject the terms and conditions of the solicitation may be excluded from consideration.

1. Dun & Bradstreet Number (DUNS), CAGE Code, and Tax Identification Number (TIN).

1. Cost/Price proposal:

1. SF33, Pricing, Certifications/Representations, shall not be addressed separately from that submitted in Volume I - Business Proposal. Price information shall be included in Volume I only and shall not be discussed or exhibited in any other part of the Offeror's proposal.

1. Offeror's proposal must stipulate that it is predicated upon all the terms and conditions of this RFP.

1. OCI Mitigation Plan (if required).

VOLUME II – Non-Cost/Price Technical: Non-cost/price proposals are limited to 65 single-sided pages. Pages should be numbered consecutively throughout the document and not by sections.

Pages should be numbered consecutively throughout the document and not by sections. Pages exceeding the specified limit will be removed and not forwarded for evaluation. The following sections are not subject to page limits:

Table of Contents Title page Contractor POC Cover Page Quality Management Plan Resumes and letters of intent for Key Personnel

VOLUME III – Past Performance: This volume shall contain past performance information regarding similar contracts in size, complexity and scope. This volume shall not exceed 15 pages for the prime contractor and five (5) additional pages for each subcontractor (5 pages per sub). Offeror shall submit a listing of no more than three (3) references for Government and/or commercial contracts for the prime Offeror and one (1) reference for each subcontractor during the past three years which are relevant to the efforts required by this solicitation. Relevant efforts are defined as services/efforts that are the same as or similar to the effort required by the solicitation. Data concerning the Offeror shall be provided first, followed by each proposed subcontractor, in alphabetical order. Letters of commitment shall be included for all subcontractors for their past performance to be considered. This volume shall be organized in the following sections:

Section 1 – Contract Descriptions. This section shall include the following information in the following format.

Contractor/Subcontractor place of performance, CAGE Code and DUNS Number. If the work was performed as a subcontractor, also provide the name of the prime contractor and POC within the prime contractor organization (name, and current address, e-mail address, and telephone and fax numbers).

Government contracting activity, and current address, Procuring Contracting Officer’s name, e-mail address and telephone.

Government’s technical representative/COR and current email address and telephone.

Government contract administration activity and the Administrative Contracting Officer’s name, and current e-mail address and telephone.

Contract Number and, in the case of Indefinite Delivery type contracts, GSA contracts, and Blanket Purchase Agreements, include Delivery Order Numbers.

Contract Type (specific type such as Fixed-Price (FP), Cost Reimbursement (CR), Time & Material (T&M), etc.). In the case of Indefinite Delivery contracts, indicate specific type (Requirements, Definite Quantity, and Indefinite Quantity) and secondary contract type (FP, CR, T&M, etc.).

Awarded price.

Final or projected final price.

Period of Performance dates.

Section 2 – Performance. Offeror's shall provide a specific narrative explanation of each contract listed in Section 1, Contract Description, describing the objectives achieved and detailing how the effort is relevant to the requirement of this RFP. It is not sufficient to state that it is similar in magnitude and scope, a rationale must be provided to demonstrate that it is comparable. Projects completed or in progress described in the narrative will be evaluated.

The Offerors shall indicate if any of the contracts listed were terminated and the type and reasons for the termination.

Section 3 – Subcontracts. (If applicable) Offerors shall provide an outline of how the effort required by the RFP will be assigned for performance within the Offeror’s corporate entity and among the proposed subcontractors, efforts performed by subcontractors require Contracting Officer approval at all tiers. The information provided for the prime Offeror and each proposed subcontractor must include the entire company name, company address, CAGE Code, DUNS Number and type of work to be performed by citing the applicable Government PWS subparagraph number. This section will further include written consent of subcontractors to allow the disclosure of their subcontractor’s past performance information to the Offeror.

Past Performance Questionnaire. Offerors shall provide past performance information for the past 3 years of similar scope, size, complexity and subject matter expertise in accordance with the solicitation. For all contracts identified in Section 1, Contract Descriptions, a Past Performance Questionnaire (Solicitation Section J attachment S4) must be completed and submitted. The Offeror shall e-mail the questionnaire to both the Government contracting activity and technical representative responsible for the past/current contract. The POCs shall be instructed to electronically complete the questionnaire and e-mail the entire questionnaire to the Contract Specialist no later than the proposal due date: The Offeror shall e-mail to the Contract Specialist a list of all the POC’s who were sent a questionnaire. The Government must receive this list no later than the proposal due date. The POC List shall be submitted in MSWord for Windows Table Format to include the following fields: Solicitation Number; Company Name; Contract Number; Government Agency; POC Last Name, First Name; POC Title; POC Telephone Number; POC E-mail Address; and Date E-Mail to POC (month/day). The POCs must be either Government personnel (civil service or military) or employees of private sector clients (such as public or private sector medical facilities) with whom you have provided services. Information provided by or for POCs who work directly for your company, or indirectly (i.e. in a prime or subcontractor relationship), will NOT be considered relevant. Offerors shall ensure that contact information for designated references is accurate and up-to-date.

Information from Other Sources: The Government may consider information obtained through other sources.

Small Business Particpation Plan should be included in volume III.

NON-COST/PRICE PROPOSAL CONTENT INSTRUCTIONS. The Offeror’s non-cost/price proposal shall clearly reflect the Offeror’s approach to execute and comply with the performance requirements identified in the PWS, regardless of the Government’s estimated effort. Your non-cost/price proposal, including any supporting documentation, is to be clear and concise. The level of effort proposed must be consistent with the proposed solution outlined in your non-cost/price proposal. The proposal must fully document and substantiate a cross mapping of your cost/price approach as it equates to the non-cost/price proposal. If you intend to use any labor categories that you feel are consistent in duties with the level of effort labor categories but are titled differently, in accordance with your cost accounting procedures, you must cross map those labor categories to the Government’s PWS to ensure your proposal receives a proper evaluation.

The Offeror’s non-cost/price proposal shall contain the following:

FACTOR 1: Technical/Scientific Approach: The Offeror shall submit a Technical/Scientific Approach which effectively demonstrates the Offeror’s clear understanding of all the tasks and how the approach is likely to yield the required results within the required time frame. Additionally, the Offeror shall demonstrate the methodology and flexibility that will be used in accomplishing any resultant award.

The Offeror should describe, in detail, its technical approach and overall ability to perform Non Personnel Services Support for Walter Reed Army Institute Research (WRAIR), US Military Human Immunodeficiency Virus (HIV) Research Program (MHRP), Department of Laboratory Diagnostics and Monitoring (DLDM) and Department of Epidemiology and Threat Assessment (DETA). This description should specifically address the Offeror’s approach for:

1. Execution of all phases of clinical screening (serological/protein), supplemental confirmatory testing, clinical monitoring (viral load), and therapeutic monitoring (resistance genotype testing) for prevalent and emerging infectious pathogens; i.e., public/global health, diagnostic, clinical, applied research/study support for MHRP, WRAIR, vaccine, therapeutic, cure clinical trials/studies of infectious pathogens;

1. Execution of all phases of translational research for evaluation of new/novel products for Premarket Approval (PMA) to the U.S. Food and Drug Administration (FDA) and/or execution in clinical diagnostic and/or research settings;

1. Design, develop, evaluate, validate LDAs for detection, screening, supplemental confirmatory testing/diagnosis, and/or monitoring (viral load/resistance genotyping) of prevalent and emerging infectious pathogens;

1. Conduct comprehensive characterization of the epidemiology of infectious pathogens;

1. Conduct threat assessment studies of HIV/HIV-related and emerging BBIs and TTIs associated with the battlefield blood supply among U.S. and foreign Military personnel;

1. Conduct threat assessment studies of prevalent and emerging infectious pathogens among populations of interest to the CoCOMs and in geographic regions of U.S. military operational significance;

1. Understanding of and ability to utilize instrumentation listed on Equipment attachment.

1. Execution of all tasks in accordance with applicable laws, regulations, approvals and procedures required specifically for (1) regulated clinical testing of human and animal biological specimens; (2) clinical research, threat assessment studies, public health evaluations, non-clinical research, applied research; (3) human subjects and bio-behavioral research.

1. Transition In Plan. A detailed draft transition-in plan which addresses the specific requirements in the PWS and is achievable.

FACTOR 2: Quality Management Approach(QMA): The QMP shall document how the Contractor will meet and comply with the quality standards established in this PWS. The Offeror shall include as an attachment to the non-cost/price proposal a Quality Management Plan (QMP), which specifically addresses the following:

1. The QMP should address CAP/DOD CLIP compliance, Regulatory Compliance in accordance with US FDA Notice of Inspection, the US FDA Human Subjects Protection, and IRB approved non-human subjects and human subjects research compliance as well as the maintenance, advancement, and integration of the 12 Quality System Essentials (QSEs) into the QMP.

1. The QMP should also address and insure the seamless integration of all the DETA and DLDM requirements to include HDRL, LDL, TAL, and CEU to ensure best in class clinical screening, supplemental confirmatory testing, pathogen infection classification, and monitoring (viral load/genotype), parasite identification/speciation services for US Service members, their Beneficiaries, and all translational, vaccine, therapeutic, cure, and investigative and evaluation activities.

1. The QMP should also provide a methodology to obtain data, assess processes, identify parameters, correct and monitor compliance as integrated into the QMP as identified in paragraph 4.10 in the PWS.

FACTOR 3: Experience: The Offeror should submit written information which effectively demonstrates the Offeror’s relevant experience (for this purpose, experience refers to what an Offeror has done, not how well it was accomplished) identical to, similar to or related to performing services contained within the PWS. The Offeror’s proposal shall demonstrate the amount of relevant corporate experience the Offeror possesses. Offeror’s relevant experience shall support and substantiate that the organization (to include support contractors, consultants, key personnel, and business partners) has current capabilities for assuring performance of this requirement. Experience shall specifically show the following:

1. Corporate Experience conducting clinical trials/studies in support of manufacturer Pre-market Approval(PMA) submission for approval and/or licensure of assays and/or platforms through FDA submission process.

1. Corporate experience in the areas of program management, client services support, and administrative support services in a regulated laboratory and scientific environment.

1. The demonstrated experience of key personnel Resumes proposed to fill Key Personnel positions. Per attachment: PWS-P14: DLDM and DETA Key Personnel.

FACTOR 4: Staffing Approach: The Offeror should submit written information that shall describe the Offeror’s Staffing Approach that will lead to the successful accomplishment of the requirement. The Offeror shall include a Staffing Plan, which shall not exceed 25 single-sided pages that should specifically address the following:

1. A clear delineation of the lines of authority associated with the proposed organization and how its methodologies, processes and capabilities will contribute in a positive manner to ensuring completion of all the tasks in the PWS (particularly emphasizing communications) and includes the following:

1. A Staffing Approach that will retain and attract a quality staff to lead to the successful accomplishment of the requirement and sufficient personnel resources and flexibility to execute activities based on Government priorities.

1. A Mission-Essential Contractor services approach that demonstrates the Offeror’s methodologies, processes and capabilities to perform identified mission essential tasks.

1. A Occupational Health and Safety approach will be evaluated to ascertain the degree to which the Offeror presents an understanding and methodology to meet and comply with the Occupational Health and Safety requirements in a CONUS medical laboratory environment as established in the PWS 6.6.3.3. The Government shall evaluate the Offeror’s procedures that it shall use to provide the required safety support while mitigating health and safety risks.

FACTOR 5: Past Performance: The Offeror (Prime Contractor) shall submit no more than three (3) references of relevant contracts within the past 3 years for its own performance. The Offeror shall also submit no more than one (1) reference for each Subcontractor proposed. The contracts may be past or current as long as the performance did not end more than 3 years prior to the due date for the submission of the task order proposal, and the contracts may have been with Federal, State and/or City agencies and commercial customers.

(a) Reference Content: It is the Offeror’s responsibility to provide valid, current and verifiable references. References must include:

Name of the Organization that will be providing the reference, Name of the POC, POC Telephone Number, POC Email address, Contract Number, Period of Performance, Scope of Work

(b) POCs: The above POCs must be either Government personnel (civil service or military) or employees of private sector clients (such as public or private sector medical facilities) with whom you have provided services. Information provided by or for POCs who work directly for your company, or indirectly (i.e. in a prime or subcontractor relationship), will NOT be considered relevant. Offerors shall ensure that contact information for designated references is accurate and up-to-date. Please verify the POC prior to submitting them.

(c) Information from other sources: The Government may consider information obtained through other sources, including but not limited to Contractor Performance Assessment Reports System (CPARS) and Past Performance Information Retrieval System (PPIRS).

FACTOR 6: Small Business Participation Plan

All Offeror’s (both large and small businesses) shall submit their level of small business commitment under the proposed acquisition and their level of commitment and ability to utilize small businesses in performance of prior contracts for similar products or services. The following should show evidence in their small business participation:

(a) The extent to which such firms, as defined in FAR Part 19, are specifically identified in proposals;

(b) The extent of commitment to use such firms (enforceable commitments will be weighted more heavily than non-enforceable ones);

(c) The complexity and variety of the work small firms are to perform;

(d) The realism of the proposal;

(e) Past performance of the offeror in complying with the requirements of the clauses at FAR 52.219-8, Utilization of Small Business Concerns, and, for all large business Offeror’s, FAR 52.219-9, Small Business Subcontracting Plan;

(f) The extent of participation of such firms in terms of the value of the total acquisition;

(g) The extent to which the offeror provides detailed explanations/documentation supporting the proposed participation percentages.

Total contract value is the cumulative dollars obligated on the contract. Progress will be assessed by the contracting officer at the end of the base period, each option period, and at completion of the contract.

Small Business Participation Goal mandatory minimum shall be no less than 16%.

Category Small Business Goal (inclusive of all categories below) 16% requirement

Small Non-Disadvantaged Business 0%

FACTOR 7: Cost/Price Factor: The Offeror’s cost/price proposal shall include proposed cost/ price, be realistic for the work and skills required for contract performance; reflect a clear understanding of the requirements; and be consistent with the Offeror's proposed technical/scientific approach.

The Offeror shall submit and propose costs outlined in the Cost Schedule (Solicitation Section J Attachment S2), and propose transition cost/price separately in accordance with their transition-in plans. For Offerors with DCAA approved accounting systems, offerors shall provide evidence of such. Offerors that do not have DCAA approved accounting systems should submit the Defense Contract Audit Agency (DCAA) Pre-award Survey of Prospective Contractor Accounting System Checklist and the Standard Form 1408 (Pre-award Survey of Prospective Contractor Accounting System) (Solicitation Section J S3).

The Offeror’s proposal shall include a supplemental pricing sheet that provides a detailed breakdown of their proposed hours, labor rates, Overhead, G&A, and profit or fee including sub elements of each. The Supplemental Pricing Worksheet shall include all other direct and indirect costs including materials, equipment, travel, shipping, and any other costs associated with the performance of the resulting contract. Contractor shall ensure mathematical computations are correct. Offeror’s shall define which labor categories will be performed by a subcontractor(s) along with the subcontractor(s) company name. The offeror shall provide a detailed breakdown of the proposed labor rate for all proposed subcontractor labor. For Offerors with DCAA approved indirect rates, offerors shall provide evidence of such.

Other Direct Costs (ODCs) shall be billed on a cost reimbursable basis, not to exceed Government estimates and shall not include fee. Costs are defined as the purchase price of materials or service plus General and Administrative charges (G&A) or material handling charges (M&H).

The annually estimated plug-in dollar amounts for ODCs are to be used in the cost proposal. They are as follows:

Travel (PWS

7.3.1.3 and attachment PWS- P11)

Optional CLINs may be required to cope with periods of high intensity mission operational tempo during real world operations and/or to provide for additional skill sets or additional hours of service to support the increased mission requirements as stated in the PWS. Surge services and Optional Support required by WRAIR will be funded through exercise of optional CLIN(s) or surge CLIN(s) or both, via contract modification as required.

Annually estimated plug-in dollar amounts for short suspense CLINs and Optional CLINs are as follows:

Not inclusive of fee $ 350,000.00 Not inclusive of fee $ 350,000.00 Not inclusive of fee $ 350,000.00 Not inclusive of fee $ 350,000.00 Not inclusive of fee

Not inclusive of fee $ 350,000.00 Not inclusive of fee $ 350,000.00 Not inclusive of fee $ 350,000.00

$ 350,000.00 Not inclusive of fee

Not inclusive of fee $ 350,000.00 Not inclusive of fee $ 350,000.00 Not inclusive of fee $ 350,000.00 Not inclusive of fee $ 350,000.00 Not inclusive of fee

Not inclusive of fee $ 350,000.00 Not inclusive of fee $ 350,000.00 Not inclusive of fee $ 350,000.00 Not inclusive of fee $ 350,000.00 Not inclusive of fee

0020 (optinal) Surge DETA Services Advanced Development $ 350,000.00 Not inclusive of fee $ 350,000.00 Not inclusive of fee $ 350,000.00 Not inclusive of fee $ 350,000.00 Not inclusive of fee $ 350,000.00 Not inclusive of fee

Detailed description of the methodology used to estimate the plug-in numbers for the surge CLINs is attached to the PWS as attachment PWS-P12.

Discussions: The Government intends to evaluate proposals and award a contract without discussions. The Government reserves the right to conduct discussions if the Contracting Officer determines them to be necessary; the Contracting Officer will provide proposal revision instructions to the Offeror, as required. Therefore, the Offeror’s initial proposal should contain the Offeror’s best terms from a technical and price standpoint. All proposals shall be subject to evaluation by a team of Government personnel who will evaluate only one proposal from each prime Offeror.

Additional Information:

ALTERNATE PROPOSALS: Alternate proposals will not be evaluated by the Government.

INCUMBENT: The incumbent is Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.W81XWH-16-C-0225

SECTION M - EVALUATION FACTORS FOR AWARD

BASIS FOR AWARD

BASIS FOR AWARD (Section M)

Proposal Evaluation

Award will be made on a competitive best value basis, using “best value tradeoff” among cost/price and non-cost/price factors. A best value tradeoff process will be used, thus, the Government may elect to award to other than the lowest priced offeror, or other than the offeror with the highest rated non-cost/price proposal. Past Performance and the Small Business Participation Plan will be evaluated independently from the other non-cost/price evaluation factors using different standards. The non-cost/price evaluation factors numbered in descending order of importance, are as follows:

1. Technical/Scientific approach

2. Quality Management Approach

3. Experience

4. Staffing Approach

5. Past Performance

6. Small Business Participation Plan

Cost is the least important factor; however, as the collective non-price/cost factors begin to reach equality in the evaluation, the cost factor becomes more important in the tradeoff analysis.

Government evaluators will not assume that the Offerors possess any capabilities or knowledge unless it is specified in the proposal.

After each of the first four non-cost/price factors (Technical/Scientific approach through Staffing Approach) is rated individually, an overall rating will be assigned collectively to these factors. If any of the above non-cost/price evaluation factors receives an individual rating of “Unacceptable”, the collective overall rating will also be “Unacceptable”. Only proposals receiving an overall rating of “Acceptable” for the first four non-cost/price factors or higher will be considered for award. In addition, only prices that are determined fair/or reasonable, and realistic will be considered for award and included in the competitive range, if established.

Capital Bridge, LLC will be providing administrative support to the Government evaluation panel during this source selection. All Capital Bridge employees have signed non-disclosure agreements.

Offerors are placed on notice that initial proposals should contain the Offeror’s best terms from a technical and cost standpoint. All proposals shall be subject to evaluation by a team of Government personnel who will evaluate only one proposal from each prime Offeror.

The Government reserves the right to: reject any or all proposals, award no contract at all depending on the quality of the proposal(s) submitted, and waive informalities and minor irregularities in offers received.

FACTORS TO BE EVALUATED

The following evaluation factors will be used to evaluate each proposal:

FACTOR 1: Technical/Scientific Approach FACTOR 2: Quality Management Approach FACTOR 3: Experience FACTOR 4: Staffing Approach FACTOR 5: Past Performance FACTOR 6: Small Business Participation Plan FACTOR 7: Cost/Price

EVALUATION APPROACH

Evaluation Factors

FACTOR 1: Technical/Scientific Approach: The Offeror’s Technical/Scientific Approach will be evaluated to the degree to which it effectively demonstrates the Offeror’s clear understanding of all the tasks and how the approach is likely to yield the required results within the required time frame. Additionally, the Offeror shall demonstrate the methodology and flexibility that will be used in accomplishing any resultant award.

The Offeror’s Technical Scientific approach will be evaluated to the degree it describes a clear and complete understanding of the PWS requirements, specifically:

1. Execution of all phases of clinical screening (serological/protein), supplemental confirmatory testing, clinical monitoring (viral load), and therapeutic monitoring (resistance genotype testing) for prevalent and emerging infectious pathogens; i.e., public/global health, diagnostic, clinical, applied research/study support for MHRP, WRAIR, vaccine, therapeutic, cure clinical trials/studies of infectious pathogens;

1. Execution of all phases of translational research for evaluation of new/novel products for Premarket Approval (PMA) to the U.S. Food and Drug Administration (FDA) and/or execution in clinical diagnostic and/or research settings;

1. Design, develop, evaluate, validate LDA (Laboratory Developed Assays) for detection, screening, supplemental confirmatory testing/diagnosis, and/or monitoring (viral load/resistance…